Milestone Pharmaceuticals Inc.
MIST
$2.15
$0.073.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.07% | -47.85% | -37.46% | 5.59% | 0.89% |
| Total Receivables | -27.13% | -33.65% | -14.69% | 18.33% | -4.93% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.14% | -56.33% | -0.25% | -42.10% | -63.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -1.64% | 75.33% | 76.90% | -71.92% | -- |
| Total Current Assets | 7.01% | -47.15% | -35.64% | 1.22% | -4.49% |
|
|
|||||
| Total Current Assets | 7.01% | -47.15% | -35.64% | 1.22% | -4.49% |
| Net Property, Plant & Equipment | -37.06% | -33.32% | -30.68% | -28.30% | -26.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.10% | -46.86% | -35.54% | 0.36% | -5.06% |
|
|
|||||
| Total Accounts Payable | 95.16% | 290.92% | 38.04% | -51.47% | -12.08% |
| Total Accrued Expenses | 125.22% | 79.64% | 443.13% | 108.34% | -46.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.01% | -9.17% | -2.34% | 4.58% | 9.81% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 100.15% | 103.26% | 213.87% | 12.46% | -35.20% |
|
|
|||||
| Total Current Liabilities | 100.15% | 103.26% | 213.87% | 12.46% | -35.20% |
| Long-Term Debt | 7.19% | 7.19% | 7.19% | 7.19% | 7.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -48.20% | -44.55% | -41.96% | -40.01% | -36.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.58% | 13.81% | 21.27% | 6.67% | 0.14% |
|
|
|||||
| Common Stock & APIC | 15.92% | 1.79% | 1.82% | 11.31% | 11.51% |
| Retained Earnings | -16.33% | -16.06% | -15.44% | -12.73% | -13.69% |
| Treasury Stock & Other | 4.85% | 0.00% | 0.00% | 9.53% | 9.53% |
| Total Common Equity | -14.62% | -155.49% | -115.34% | -21.61% | -15.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.62% | -155.49% | -115.34% | -21.61% | -15.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.62% | -155.49% | -115.34% | -21.61% | -15.76% |
|
|
|||||